chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Several hours after the FIRST vaccine: pain at injection site, all arm pain, weakness. The night after the vaccine and lasting 2 days: tiredness, muscles paint, paint of the shoulder, nausea, headache!!!!Alarming-4 days after the vaccination swollen lymph node in axila and visible bump from outside of axila look like absces in the fascia of deltoid muscle. It is hurting. No shrinking noted. getting bigger. Not sure if I should take the booster?
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and drug reactions or allergies were not specified. On 08-AUG-2014, the patient received an expired dose of PNEUMOVAX 23 injection, lot number J006242, expiration date 03-AUG-2014 (dose, dose number and route were not reported). No adverse effects were reported. Concomitant medications were not specified. Additional information has been requested.
An unspecified number of patients were administered with improperly stored Pneumovax23 above 47 degrees F; No additional adverse events; This spontaneous report was received from a registered nurse reporting about an unspecified number of patients of unknown age. Information about the patients' medical history, concurrent conditions or concomitant medications was not provided.     On an unknown date, the patients were vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), with lot # S033516 and expiration date of 29-JUN-2012, that was administered for prophylaxis; that was improperly stored at a temperature too high, over 47 degrees F. No additional adverse events were reported. On 09-DEC-2019, the vaccine's temperature was 50.9 degrees F for 18 minutes. On 14-JAN-2020, the vaccine's temperature was 47.1 degrees F for 15 minutes. On 31-JAN-2020, the vaccine's temperature was 62.5 degrees F for 15 minutes.
pt. was sitting and passed out about 7-10 minutes after recieving the vaccine, monitored and took blood pressure, called ambulance
Pruritic, erythemic rash developed on left upper arm. Rash was approximately 10x12mm located over the bicep.
This is an instance of breakthrough disease, after which death occurred.   The individual was vaccinated with the Moderna COVID-19 vaccine on 02/01/2021, 03/01/2021, and 11/03/2021.   The individual presented to an emergency department on 11/26/2021 in respiratory distress and tested COVID-19 positive the same day. It is not specifically known when symptom onset was.  The individual was admitted to hospital on 11/26/2021, where their condition continued to deteriorate until their death on 11/30/2021.  This individual had numerous underlying medical conditions.   Death Certificate details are as follows:   Part I Cause of Death A: Septic Shock B: Cholecystitis C: Cellulitis of Abdominal Wall Part II Other Significant Conditions: End Stage Renal Disease, Diabetes Type 2, Hypertension, Diastolic Heart Failure, COVID 19
Mild pain at injection site; fever of 99.9; chills (mild); Achy all over(moderate); Feeling worn down; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose BNT162b2 (PFIZER- BIONTECH COVID-19 m RNA vaccine, lot no: unknown) via unspecified route of administration in left arm on 23Mar2021 at 13:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, high triglycerides. No allergies to medications, food, or other products were reported. Concomitant medication included amlodipine(NORVASC), fenofibrate (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) all taken for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER- BIONTECH COVID-19 m RNA vaccine, lot no: unknown) via unspecified route of administration in left arm on 02Mar2021 at 13:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021 at 10:00, the patient experienced vaccination site pain, fever, chills, general body pain and was worn out. The patient had mild pain at injection site, fever of 99.9, chills (mild), achy all over (moderate) and was feeling worn down. No treatment was received for the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of all the events vaccination site pain, fever, chills, general body pain, worn out were resolved on an unknown date.   No follow-up attempts are possible; information about lot number cannot be obtained.
Had pain /stabbing needle pain in his bones, bilat leg weakness, was unable to leave room x 2 months, used commode fatigue, Couldn't walk at the time, did commode by bedsde, then after 2 mos at least he could walk to BR,   has residual, chronic with right leg weakness he was not treated at the time, had blood test and video visit June 2021 seen in office 8/8/22, noted to have right leg weakness, using walker working diagnosis, possible transverse myelitis or stroke
Body swelled p/shot 24MAY92 & urticaria all over body 12JUN92 & swelling; could not breath; whole head swelled up 13JUN92; head swells everyday, thyroid affected;
For the first two three the patient experienced the worst headaches that she had ever had. Also extreme tiredness. The headaches lasted lasted most days for two weeks,  though only occasionally were they as extreme as during the first three days. A visit to the emergency on 11/05/22 did not reveal any cause for the headaches or tiredness. Treatment was Tylenol and Ibuprofin.
Information has been received from a physician concerning a male pt who on 9/9/06 was vaccianted with a dose of varicella zoster virus vaccine live. On 9/8/06 the pt was hospitalized with a rash. The was diagnosed with a zoster infection. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Clinic Nurse Reports: Pt received covid vaccine and had to wait 30 min due to anaphlyaxis with shellfish. Toward the end of observation, pt began to complain of itching in mouth, ear, and throat, along with tightness around mouth. Obtained VS, called EMS, and administered 1mL of diphenhydramine.
Adjuvant vial incorrectly capped; Dose was given without using the antigen; Dose was given without using the antigen; This case was reported by a physician via sales rep and described the occurrence of inappropriate preparation of medication in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number 2459K, expiry date 27th May 2023) and (batch number N3545, expiry date 27th May 2023) for prophylaxis. This case was associated with a product complaint.   On 3rd March 2022, the patient received Shingrix .5 ml. On an unknown date, the dose was an unknown dose. On 3rd March 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered and pharmaceutical product complaint were unknown.  Additional details were provided as follows: The reporter stated that, the office had a Shingrix adjuvant vial with a brown cap.  Two vials of adjuvant were used, and the dose was given to the patient without using the antigen, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  The GlaxoSmithKline field representative had driven out to the healthcare professional office on the date of reporting and stated that, the rest of the vials in the box were capped correctly.  He took pictures of the 2 adjuvant vials used and would be sending the picture to GlaxoSmithKline. The agent called the healthcare professional to confirm and obtain further information for the case.  As per the healthcare professional, the defect was not noticed until after the vaccine was administered. The reporter consented to follow up.
Diagnosed with SVT 2 weeks after covid vaccine. Needed cardiac ablation to stop episodes.
Information has been received regarding a case in litigation from a lawyer regarding a patient of unknown age and gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history. In November 2012, the patient was vaccinated with ZOSTAVAX, (dose, route, anatomical location, lot number and expiration date were not reported) to obtain permanent prevention and protection against shingles and zoster-related injuries (prophylaxis) as recommended by the healthcare professional. On an unknown date, the patient experienced shingles (herpes zoster) and on 10-DEC-2016, the patient was treated for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX (vaccination failure) and suffered serious physical, emotional, and economic damages (emotional distress), as a result of patient's injuries. The patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffered (emotional distress, pain); extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (condition aggravated); lost wages; loss of earnings capacity; and other losses and damages. At the time of the report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The reporter considered all aforementioned adverse events to be related to ZOSTAVAX. The reporter considered the events to be disabling, life-threatening and medically significant.
Pt presented at pharmacy on 5/6/12 stating she received BOOSTRIX injection. On 4/23/12 & that she still has small knot under skin at inj. site. There was slight pain if the site was touched. On 5/15/12, I advised pt that she should follow pt wit PCP. She stated that it was increased in size and no longer painful or tender. I told her that I would follow up with her in 1 week.
Flu like symptoms; mental health issue; Fatigue; Ache/Pain; She got very angry and tried to convince her husband to get a divorce/She also sent angry emails to companies and individuals that have wronged her some how; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid left, administration date 12Apr2021 13:30 (Lot number: EW0153) at the age of 42 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (lot number:EN6208, Dose Number:1, Anatomical site of injection: Left Shoulder), administration date: 22Mar2021, for COVID-19 immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 13Apr2021, outcome "recovered" (15Apr2021), described as "Flu like symptoms"; MENTAL DISORDER (non-serious) with onset 13Apr2021, outcome "recovered" (14Apr2021), described as "mental health issue"; FATIGUE (non-serious) with onset 13Apr2021, outcome "recovered" (15Apr2021), described as "Fatigue"; PAIN (non-serious) with onset 13Apr2021, outcome "recovered" (15Apr2021), described as "Ache/Pain"; ANGER (non-serious) with onset 13Apr2021, outcome "recovered" (15Apr2021), described as "She got very angry and tried to convince her husband to get a divorce/She also sent angry emails to companies and individuals that have wronged her some how"; HEADACHE (non-serious) with onset 13Apr2021, outcome "recovered" (15Apr2021), described as "Headache".  Additional info: She had flu like symptoms for 2 days like many other people have had. She had side effect of the vaccine. The symptoms were the worst the 13Apr2021 and 14Apr2021. She was worried something was wrong with her brain. She doesnt understand why that happened. She has had no further episodes like that. No history of all previous immunization with the Pfizer vaccine considered as suspect. No additional Vaccines Administered on Same Date of the Pfizer Suspect.  No follow-up attempts are possible. No further information is expected.
Information has been received from a registered nurse concerning a 14 week old female who on 01-FEB-2008 was inadvertently vaccinated PO with her first dose of ROTATEQ (lot# 657986/1205U). The patient did not experience any difficulties since the first dose. The patient sought unspecified medical attention. There was no product quality complaint. Additional information has been requested.
Information has been received from an NP concerning an adult female who was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (Lot # 641116/1160L).  Subsequently, the patient developed redness and swelling.  The patient was treated with warm compress, acetaminophen (TYLENOL) and diphenhydramine HCl (BENADRYL).  The nurse indicated that she would like a lot check performed on lot # 641116/1160L.  The records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory.  The lot complies with the standards of the Center for Biologics Evaluation and Research and was released.  It was also reported that four other adult females (WAES # 0210USA02724, 0210USA02963, 0210USA02964, 0303USA02211) and a male (WAES # 0303USA02104) had a similar experience.  No additional information is expected.
Sore throat, chills, achiness, exhausted diarrhea, 10/30/2008. Better on Tues. 11/4/08.
Diaphoresis, palpitations ~20 minutes post vaccination followed by dizziness and throat tightness.  cetirizine 10mg  benadryl 50mg albuterol inhaler x2 puffs   returned to baseline after 1 hour obs, discharged in stable condition
A report has been received from a Health Professional concerning, subject of unknown gender, who had been receiving FLUMIST. The patients concurrent disease(s) included Asthma and Bronchospasm. FLUMIST started on an unknown date. THe patient experienced Pnemonia. The outcome of the event of Pneumonia is unknown. The report was considered to be non-serious.
6x6 cm erythema with 4 cm2 induration 48 hr after injected in office.
tremors; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (tremors), HEADACHE (headache) and PYREXIA (fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced TREMOR (tremors), HEADACHE (headache) and PYREXIA (fever). At the time of the report, TREMOR (tremors), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had put ice on the back of her neck.
patien received dose 2 of the Pfizer COVID vaccine (lot EW0161, exp 7/2021) at approximately 1110. At 1125, patient reported to EMT and EMT that she felt chest tightness, feeling sweaty and like she needed to burp. Patient moved unassisted to zero-gravity chair and placed supine. PHN approached to assess, patient denied shortness of breath, dizziness, pain radiating, numbness or tingling of extremities, headache or swelling. Patient reported eating breakfast and consuming tea. Patient reported allergies to morphine and seasonal allergens. Medical conditions include hypertension and varicose veins. Medications include atenolol that the patient takes regularly, last dose the evening before. Patient reported fear of needles and history of panic attacks. PHN offered Benadryl but patient declined. PHN encouraged patient to follow up with provider. Vital signs at 1125: blood pressure 164/94, pulse 80, O2 97%, respirations 18. At 1130, patient reported symptoms were improving and reduced sense of anxiety. Vital signs blood pressure 178/110, pulse 77, O2 97%. At 1133, patient reported symptoms had resolved. At 1140, vital signs: blood pressure 158/88, pulse 76, O2 97%, respirations 16. Vital signs at 1155: blood pressure 156/86, pulse 63, O2 98%, respirations 16. Patient sat up with assistance of EMT. EMT explained to patient when to call 911. Patient left with husband, walking with steady gait at 1200.
Headache for 2 weeks; Light headed and dizzy for 2 weeks; This is a spontaneous report from a contactable consumer (patient). A 62-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EN6208) via an unspecified route of administration, administered on the left arm on 20Mar2021 13:30 as single dose for COVID-19 immunisation. Medical history included COVID-19 (prior vaccination). Concomitant medication included ixekizumab (TALTZ). On 21Mar2021 12:00 AM, the patient experienced light headed and dizzy for 2 weeks, headache for 2 weeks. No treatment was received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Post vaccination, the patient has not been tested for COVID-19. No known allergies. Outcome of the events was not recovered.
SWOLLEN EYES; HIVES IN THE EYES; ITCHY EYES; FEELING JITTERY; CONGESTION; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: D41A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced feeling jittery. On APR-2021, the subject experienced congestion. On 10-APR-2021, the subject experienced itchy eyes. Treatment medications included: diphenhydramine hydrochloride. On 11-APR-2021, the subject experienced swollen eyes. On 11-APR-2021, the subject experienced hives in the eyes. Treatment medications included: diphenhydramine hydrochloride. On 12-APR-2021, treatment medications included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from itchy eyes, swollen eyes, and hives in the eyes on APR-2021, and had not recovered from feeling jittery, and congestion. This report was non-serious.
Rec'd shots in the am = DTaP, HIB, Hep B. Home - took a  nap - upon waking mom noted baby shaking - called my office advised to CI now = upon arrival noted to be having seizure = eyes, mouth, arms & legs twitching lasted approximately 10 mins.
Moderna COVID-19 Vaccine EUA On Jan. 28th my knees and hips began to hurt.  I have osteoarthritis in my left knee and right hip as well as a left hip  replacement and right knee replacement I thought perhaps the pain I experienced was weather related as I had not experience pain in these joints like this before.  I went to bed that night about 9 p.m. and was experiencing more pain in my legs.  The pain kept me awake most of the night and I got up about 4:30 a.m. By then I could barely walk.  The pain was not only in my joints but felt like it was in my bones as well.  My skin on the lower leg felt tight, almost like my legs were swollen, but they did not appear to be.  My right leg hurt the worst.   I still have a discolored spot on my arm where I had the shot.  It is about a 1/2" diameter.  It does not hurt.
After two hours I started to feel itchy in my private area (same effect as when I experience allergic reaction to clams), my mouth went numb and then I started to feel swollen face and throat.  Effects were gone about 30 min later.  Shortly after, I started to experience chest pain and at about 4 am the following day, I woke up suddenly gasping for air.
significant muscle aches; chills; joint pain; Neck pain with headache that night; Neck pain with headache that night; This is a spontaneous report from a non-contactable healthcare professional. A 45-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as COVID 19 vaccine; unknown lot number and expiration date), intramuscular right arm on 06Jan2021 14:00 [02:00 PM] at a single dose for covid-19 vaccination. Medical history included breast cancer and had covid-19 prior vaccination. The patient has no known allergies. Concomitant medication included tamoxifen (TAMOXIFEN). The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her most recent COVID-19 vaccine in a hospital. The patient experienced neck pain with headache that night (06Jan2021 22:00 [10:00 PM]) then next day (07Jan2020), significant muscle aches and chills with joint pain for another day and a half. The events were considered as non-serious. It was unknown if treatment was received. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The outcome of the events was recovering.  No follow-up attempts are possible; Information about Lot/Batch could not be obtained. No further information is expected.
Arm started hurting pretty badly about 4 hours after getting the shot. Around 9 PM I started vomiting and shaking uncontrollably. This lasted about two hours. I started shaking again but less so around 11PM--seemed similar to chills but the shaking was pretty spasm like.  Headache afterwards. Sweating the next day but the majority of the effect was the day of.
Pt was give 1 dose of MENACTRA that had expired 2 days before no problems.
it really affected their back/ He said his back pain was debilitating for 2 weeks; This spontaneous case was reported by an other health care professional and describes the occurrence of BACK PAIN (it really affected their back/ He said his back pain was debilitating for 2 weeks) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Back discomfort (Issue with back problems).    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (it really affected their back/ He said his back pain was debilitating for 2 weeks). At the time of the report, BACK PAIN (it really affected their back/ He said his back pain was debilitating for 2 weeks) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered BACK PAIN (it really affected their back/ He said his back pain was debilitating for 2 weeks) to be related.    No concomitant medication was reported.  Patient recently got the bivalent COVID booster shot and it really affected patient's back. Patient said he had gotten the booster 6 months ago before getting this bivalent shot. Patient had an issue with back problems and had been getting steroid shots in the back and had been pushing off surgery for it. But after getting the booster, patient was really considering it. Patient's back pain was debilitating for 2 weeks but reporter believed it was okay now.